Sort
53,477 grants matching “addiction”
NPQ/Spexin the Endogenous Ligand for the Galanin Receptor 3
$606,803Lawrence R Toll · Florida Atlantic University · R01 · FY2018 · DA
Therapeutic Communities:Management and Performance
$606,784University Of Georgia (Uga) · R01 · FY2002 · DA
Electrophysiological and electrochemical studies of addictive drugs
$606,540Eugene A Kiyatkin · National Institute On Drug Abuse · ZIA · FY2021 · DA
Novel use of mHealth data to identify states of vulnerability and receptivity to JITAIs
$606,526Inbal Billie Nahum-Shani · University Of Michigan At Ann Arbor · U01 · FY2019 · CA
Effects of Stereotype Threat on Impulsivity and Its Relation to Alcohol Use in African Americans: An fMRI Study
$606,500Uraina S Clark · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · AA
Compounded Neuronal Damage in Comorbid Cigarette Smoking and Addiction
$606,456Karmen K Yoder · Indiana University Indianapolis · R01 · FY2018 · AA
Neurocircuitry of clinical insight predicting relapse outcomes in opioid addiction
$606,360Scott J Moeller · State University New York Stony Brook · R01 · FY2022 · DA
Neurocircuitry of clinical insight predicting relapse outcomes in opioid addiction
$606,360Scott J Moeller · State University New York Stony Brook · R01 · FY2021 · DA
Neurocircuitry of clinical insight predicting relapse outcomes in opioid addiction
$606,360Scott J Moeller · State University New York Stony Brook · R01 · FY2023 · DA
Teenage Stimulant Use: Neurally Plausible Spontaneous and Protective Processes
$606,300Alan W Stacy · Claremont Graduate University · R01 · FY2011 · DA
A Neuroecological Approach to Examining the Effects of Early Life Adversity on Adolescent Drug Use Vulnerabilities Using the ABCD Dataset
$606,299Assaf Oshri · University Of Georgia · R01 · FY2025 · DA
A Neuroecological Approach to Examining the Effects of Early Life Adversity on Adolescent Drug Use Vulnerabilities Using the ABCD Dataset
$606,299Assaf Oshri · University Of Georgia · R01 · FY2024 · DA
Delineating the role of serotonin 5-HT2 receptors in opioid use disorders:Development of novel 5-HT2 modulators with translational studies in rodents andprimates
$606,215Raymond G Booth · Northeastern University · R01 · FY2021 · DA
Deciphering genes and pathways in nicotine dependence
$606,211Ming D Li · University Of Virginia · R01 · FY2008 · DA
Treatment of Nicotine Dependence Among Hypertensives
$606,141University Of Texas Md Anderson Can Ctr · R01 · FY2001 · CA
Methodology and measurement for examining short-term and long-term effects of e-cigarette and polysubstance use
$606,098Yuh-Pey Anne Buu · University Of Texas Hlth Sci Ctr Houston · R01 · FY2019 · DA
Project 2: Using user behavior data collected in the clinical lab to test hypotheses about advanced-generation ECIGs and generate population-level predictions regarding potential regulatory action
$606,063Alison Breland · Virginia Commonwealth University · U54 · FY2021 · DA
Neurocircuitry of motivated reward-seeking after stress
$606,029Andrew R Tapper · Univ Of Massachusetts Med Sch Worcester · R56 · FY2024 · MH
IV COCAINE ABUSE TREATMENT: A LABORATORY MODEL
$606,027Columbia University Health Sciences · R01 · FY2005 · DA
Therapeutic Strategy to Treat Alzheimer's Disease by VGF Delivery into Brain
$606,012Jagdish Singh · North Dakota State University · R01 · FY2025 · AG
Design, synthesis and characterization of dopamine receptor 3 ligands
$605,960Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2010 · DA
HIV and Psychiatric Comorbidity: Selected Genetic and Epigenetic Factors
$605,946Mary J Kreek · Rockefeller University · R01 · FY2008 · MH
Effective Treatment for Prescription Opioid Abuse
$605,943Stacey C Sigmon · University Of Vermont & St Agric College · R01 · FY2009 · DA
The Impact of Opioids on Health Outcomes for Hospitalized Infants
$605,870Lorraine I Kelley-Quon · Children'S Hospital Of Los Angeles · R01 · FY2024 · HD
Employment-based Depot Naltrexone Clinical Trial
$605,836Kenneth Silverman · Johns Hopkins University · R01 · FY2015 · DA